Metabolic syndrome in subjects with white-coat hypertension: Impact on left ventricular structure and function

Journal of Human Hypertension

Volumn 21, Issue 11, 2007, Pages 854-860

  Mule G ^a   Nardi, E ^a   Cottone, S ^a   Cusimano, P ^a   Incalcaterra, F ^a   Palermo, A ^a   Giandalia, M ^a   Geraci, C ^a   Buscemi, S ^a   Cerasola, G ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD CHEMISTRY; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; DECELERATION; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREVALENCE; WAVEFORM; WHITE COAT HYPERTENSION;

ADULT; AGED; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; METABOLIC SYNDROME X; MIDDLE AGED; VENTRICULAR FUNCTION, LEFT;

EID: 35649024781     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/sj.jhh.1002238     Document Type: Article

References (30)

1. Pickering TG, Coats A, Mallion JM, Mancia G, Verdecchia P. Task force V: white-coat hypertension. Blood Press Monit 1999; 4: 333-341.
2. Chung I, Lips GYH. White coat hypertension: Not so benign after all? J Hum Hypertens 2003; 17: 807-809.
3. Palatini P, Mormino P, Santonastaso M, Mos L, Dal Follo M, Zanata.G et al. Target-organ damage in stage I hypertensive subjects with white coat and sustained hypertension. Results from the HARVEST study. Hypertension 1998; 31: 57-63.
4. Sega R, Trocino G, Lanzarotti A, Carugo S, Cesana G, Schiavina R et al. Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension. Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni (PAMELA) Study). Circulation 2001; 104: 1385-1392.
5. Cerasola G, Cottone S, Nardi E, D'Ignoto G, Volpe V. Mulè G et al. White-coat hypertension and cardiovascular risk. J Cardiovasc Risk 1995; 2: 545-549.
6. Glen SK, Elliott HL, Curzio JL, Rees KR, Reid JL. White-coat hypertension as a cause of cardiovascular dysfunction. Lancet 1996; 348: 654-657.
7. Rizzo V, Cicconetti P, Bianchi A, Lorido A, Morelli S, Vetta F et al. White-coat hypertension and cardiac organ damage in elderly subjects. J Hum Hypertens 1996; 10: 293-298.
8. Manning G, Rushton L, Millar-Craig MW, Clinical implications of white coat hypertension: An ambulatory blood pressure monitoring study. J Hum Hypertens 1999; 12: 817-822.
9. Muldoon MF, Nazzaro P, Sutton-Tyrrell K, Manuck SB. White-coat hypertension and carotid artery atherosclerosis. A matching study. Arch Intern Med 2000; 160: 1507-1512.
10. Zakopoulos N, Papamichael C, Papaconstantinou H, Dubbins PA, Burrell CJ, Lekakis J et al. Isolated clinic hypertension is not an innocent phenomenon. Effect on the carotid artery structure. Am J Hypertens 1999; 12: 245-250.
11. Cavallini MC, Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB. Is white coat hypertension associated with arterial disease or left ventricular hypertrophy? Hypertension 1995; 26: 413-419.
12. Julius S, Mejia A, Jones K, Krause L, Schork N, Van de Ven C et al. 'White coat' versus 'sustained' borderline hypertension in Tecumseh, Michigan. Hypertension 1990; 16: 617-623.
13. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Porcellati C. White coat hypertension. Lancet 1996; 348: 1444-1445.
14. Khattar AS, Senior R, Lehiri A. Cardiovascular outcome in white-coat versus sustained mild hypertension: A 10-year follow-up study. Circulation 1998; 98: 1892-1897.
15. Strandberg TE, Salomaa V. White coat effect, blood pressure and mortality in men: 'prospective cohort study. Eur Heart J 2000; 21: 1714-1718.
16. Gustavsen PH, Hoegholm A, Bang LE, Kristensen KS. White coat hypertension is a cardiovascular risk factor: A 10-year follow-up study. J Hum Hypertens 2003; 17: 811-817.
17. Verdecchia P, Reboldi GP, Angeli F, Schillaci G, Schwartz JE, Pickering TG et al. Short- and long-term incidence of stroke in white-coat hypertension. Hypertension 2005; 45: 203-208.
18. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol 2006; 21: 1-6.
19. Mule G, Nardi E, Cottone S, Cusimano P, Volpe V, Piazza G et al. Influence of metabolic syndrome on hypertension-related target organ damage. J Intern Med 2005; 257: 503-513.
20. Mule' G, Cerasola G. The metabolic syndrome and its relationship to hypertensive target organ damage. J Clin Hypertens (Greenwich) 2006; 8: 195-201.
21. Björklund K, Lind L, Vessby B, Andrén B, Lithell H. Different metabolic predictors of white-coat and sustained hypertension over a 20-year follow-up period. Circulation 2002; 106: 63-68.
22. Kario K, Pickering T. White-coat hypertension or white-coat hypertension syndrome: Which is accompanied by target organ damage? Arch Intern Med 2000; 160:3497-3498.
23. Pickering TG, Kario K. Comments on the study of Zakopoulos et al., Am J Hypertens 1999; 12: 1158-1160.
24. Sahn DJ, DeMaria A, Kisslo J, Weiman A. The Committee on M-mode standardization of the American Society of Echocardiography. Circulation 1978; 58: 1072-1073.
25. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458.
26. de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH. Effect of growth on variability of left ventricular mass: Assessment of allometric signals in adults and children and of their capacity to predict cardiovascular risk. J Am Coll Cardiol 1995; 25: 1056-1062.
27. Liao Y, Cooper RS, Durazo-Arvizu R, Mensah GA, Ghali GK. Prediction of mortality risk by different methods of indexation for left ventricular mass. J Am Coll Cardiol 1997; 29: 641-647.
28. de Simone G, Devereux RB, Roman MJ, Ganau A, Saba P, Aldermann MH et al. Assessment of left ventricular function by the midwall fractional shortening/endsystolic stress relation in human hypertension. J. Am Coll Cardiol 1994; 23: 1444-1451.
29. Tunckale A, Aran SN, Karpuz H, Dirican A. Relationship between insulin resistance and end-organ damage in white coat hypertension. Am J Hypertens 2004; 17: 1011-1016.
30. Julius S, Li Y, Brant D, Krause L, Buda A. Neurogenic pressor episodes fail to cause hypertension, but do induce cardiac hypertrophy. Hypertension 1989; 13: 422-429.